T900607 in Treating Patients With Gastroesophageal Junction Cancer

NCT00054249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: T900607

Sponsor

University Hospitals Seidman Cancer Center

Collaborators

[object Object]